Virus News and Research

Latest Virus News and Research

Study demonstrates long-term neuropsychological consequences following SARS-CoV-2 infection

The study, published in the pre-print server medRxiv, demonstrates the presence of long-lasting neuropsychological sequelae after COVID-19, regardless of the respiratory disease's severity.

2 Mar 2021

SARS-CoV-2 viremia predicts severe COVID-19 disease outcomes

The SARS-CoV-2 plasma viremia has been linked to severe disease and death in COVID-19 cases in small-scale cohort studies. The current study, published on the pre-print server medRxiv, aimed to study the mechanisms behind this relationship.

2 Mar 2021

Early antibody response predicts COVID-19 outcome

To address this gap, researchers from the U.S. evaluated the timing of antibody production against SARS-CoV-2 in hospitalized patients. They used a highly sensitive multiplexed bead-based immunoassay that allows for early detection of anti-SARS-CoV-2 antibodies. The study is published on the preprint server medRxiv.

2 Mar 2021

Quantifying SARS-CoV-2 viral load in hospitalized patients

A new paper, published on the medRxiv preprint server, investigates the role of subgenomic RNA transcripts in SARS-CoV-2 infection. Earlier, scientists believed that subgenomic RNA could be traceable infective markers to monitor infectivity.

2 Mar 2021

Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers

Researchers at the New York State Department of Health in the United States have said concerning mutations within the B.1.526 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has recently become prevalent in New York State warrant further monitoring.

2 Mar 2021

Survey reveals impact of Pfizer-BioNTech vaccination in the UK

Researchers at Imperial College London in the UK have reported on round five of the REal-time Assessment of Community Transmission-2 (REACT-2) program – a cross-sectional community survey measuring the prevalence of antibodies against the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among adults in England.

2 Mar 2021

New computer algorithm offers a path toward pan-influenza and coronavirus vaccine

A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu also offers a path toward a pan-influenza vaccine and possibly a pan-coronavirus vaccine as well, according to a new paper published in Nature Communications.

2 Mar 2021

Study: The pandemic has worsened the condition of 70% of people with chronic pain

The pandemic has impacted significantly on people who suffer chronic pain. A study performed by the eHealth Lab, a research group affiliated with the Faculty of Health Sciences and the Universitat Oberta de Catalunya's eHealth Center, has shown that 70% of the people with chronic pain have seen their condition worsen in terms of severity, frequency of episodes and interference in their daily activities.

2 Mar 2021

Children with MIS-C have highly activated immune systems, study finds

Taking the first deep dive into how the immune system is behaving in patients with multisystem inflammatory syndrome in children (MIS-C), researchers at Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania have found that children with this condition have highly activated immune systems that, in many ways, are more similar to those of adults with severe COVID-19.

2 Mar 2021

Coronavirus-like nanoparticles could serve as a positive control for COVID-19 tests

Rapid COVID-19 tests are on the rise to deliver results faster to more people, and scientists need an easy, foolproof way to know that these tests work correctly and the results can be trusted. Nanoparticles that pass detection as the novel coronavirus could be just the ticket.

2 Mar 2021

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.

2 Mar 2021

Readers and tweeters dispense timely advice for difficult times

Your body’s immune system has produced antibodies that will kill a few thousand kinds of germs and virus. Since you are alive, the chances are quite high you will survive its producing another. Here is how the system works.

2 Mar 2021

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

A Hong Kong Baptist University-led research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein-Barr virus (EBV).

2 Mar 2021

Beijing’s SARS lockdown taught my children resilience. Your Covid kids will likely be fine.

Many parents are filled with angst as they prepare for their children to exit a year of pandemic isolation: Will it be OK to send them to school, per the recent recommendation from the Centers for Disease Control and Prevention? Will school feel like school if students are masked and can't trade snacks? Will children's development be impaired by nearly a year of seeing few friends?

2 Mar 2021

Virus News and Research

Latest Virus News and Research

Study demonstrates long-term neuropsychological consequences following SARS-CoV-2 infection

SARS-CoV-2 viremia predicts severe COVID-19 disease outcomes

Early antibody response predicts COVID-19 outcome

Quantifying SARS-CoV-2 viral load in hospitalized patients

Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers

Survey reveals impact of Pfizer-BioNTech vaccination in the UK

New computer algorithm offers a path toward pan-influenza and coronavirus vaccine

Study: The pandemic has worsened the condition of 70% of people with chronic pain

Children with MIS-C have highly activated immune systems, study finds

Coronavirus-like nanoparticles could serve as a positive control for COVID-19 tests

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

Readers and tweeters dispense timely advice for difficult times

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Beijing’s SARS lockdown taught my children resilience. Your Covid kids will likely be fine.

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model

Sorting out how politics, policies figure in flap over New York nursing home Covid death rates

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies

Optimal storage protocols of wastewater samples for SARS-CoV-2 RNA detection

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in